Structure

Physi-Chem Properties

Molecular Weight:  310.14
Volume:  310.375
LogP:  2.998
LogD:  2.543
LogS:  -3.432
# Rotatable Bonds:  6
TPSA:  85.22
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.782
Synthetic Accessibility Score:  3.393
Fsp3:  0.562
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.769
MDCK Permeability:  4.387423177831806e-05
Pgp-inhibitor:  0.01
Pgp-substrate:  0.118
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.034

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.74
Plasma Protein Binding (PPB):  87.01305389404297%
Volume Distribution (VD):  0.79
Pgp-substrate:  11.993722915649414%

ADMET: Metabolism

CYP1A2-inhibitor:  0.431
CYP1A2-substrate:  0.594
CYP2C19-inhibitor:  0.077
CYP2C19-substrate:  0.817
CYP2C9-inhibitor:  0.063
CYP2C9-substrate:  0.826
CYP2D6-inhibitor:  0.052
CYP2D6-substrate:  0.401
CYP3A4-inhibitor:  0.304
CYP3A4-substrate:  0.17

ADMET: Excretion

Clearance (CL):  12.871
Half-life (T1/2):  0.749

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.168
Drug-inuced Liver Injury (DILI):  0.244
AMES Toxicity:  0.053
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.957
Skin Sensitization:  0.519
Carcinogencity:  0.869
Eye Corrosion:  0.015
Eye Irritation:  0.43
Respiratory Toxicity:  0.83

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC82592

Natural Product ID:  NPC82592
Common Name*:   Fusarentin 6,7-Dimethylether
IUPAC Name:   (3S)-8-hydroxy-3-[(2S)-2-hydroxypentyl]-6,7-dimethoxy-3,4-dihydroisochromen-1-one
Synonyms:   Fusarentin 6,7-Dimethylether
Standard InCHIKey:  QBCACQPIGRTBHJ-QWRGUYRKSA-N
Standard InCHI:  InChI=1S/C16H22O6/c1-4-5-10(17)8-11-6-9-7-12(20-2)15(21-3)14(18)13(9)16(19)22-11/h7,10-11,17-18H,4-6,8H2,1-3H3/t10-,11-/m0/s1
SMILES:  CCC[C@@H](C[C@@H]1Cc2cc(c(c(c2C(=O)O1)O)OC)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1668327
PubChem CID:   11758702
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003411] 2-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32863 colletotrichum sp. Species Glomerellaceae Eukaryota n.a. n.a. n.a. PMID[21174408]
NPO31360 Colletotrichum Genus Glomerellaceae Eukaryota n.a. n.a. n.a. PMID[21174408]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 = 120800.0 nM PMID[541948]
NPT81 Cell Line A549 Homo sapiens IC50 > 161100.0 nM PMID[541948]
NPT793 Cell Line MOLT-3 Homo sapiens IC50 = 115300.0 nM PMID[541948]
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens IC50 > 16100.0 nM PMID[541948]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 128000.0 nM PMID[541948]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 161100.0 nM PMID[541948]
NPT1 Others Radical scavenging activity IC50 > 322000.0 nM PMID[541948]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 644000.0 nM PMID[541948]
NPT967 Individual Protein Xanthine dehydrogenase Homo sapiens IC50 > 644000.0 nM PMID[541948]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 14400.0 nM PMID[541948]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC82592 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC16082
0.9932 High Similarity NPC281477
0.9866 High Similarity NPC77679
0.9866 High Similarity NPC84935
0.9866 High Similarity NPC190020
0.9799 High Similarity NPC150227
0.9732 High Similarity NPC199926
0.96 High Similarity NPC79998
0.9536 High Similarity NPC227062
0.953 High Similarity NPC70016
0.953 High Similarity NPC215921
0.9463 High Similarity NPC96501
0.9404 High Similarity NPC116850
0.9404 High Similarity NPC144801
0.9404 High Similarity NPC197188
0.9404 High Similarity NPC238672
0.9404 High Similarity NPC291510
0.9404 High Similarity NPC43872
0.9351 High Similarity NPC24627
0.9338 High Similarity NPC295646
0.9281 High Similarity NPC54928
0.9272 High Similarity NPC200773
0.9272 High Similarity NPC228662
0.9272 High Similarity NPC240768
0.9267 High Similarity NPC270160
0.9267 High Similarity NPC237440
0.9252 High Similarity NPC51106
0.9252 High Similarity NPC469542
0.9211 High Similarity NPC167903
0.9205 High Similarity NPC469670
0.9205 High Similarity NPC469619
0.9189 High Similarity NPC210425
0.9189 High Similarity NPC86373
0.9189 High Similarity NPC280404
0.9189 High Similarity NPC277426
0.9184 High Similarity NPC469579
0.9177 High Similarity NPC20237
0.9172 High Similarity NPC249181
0.9161 High Similarity NPC470339
0.9161 High Similarity NPC329091
0.9145 High Similarity NPC473732
0.9145 High Similarity NPC204350
0.9122 High Similarity NPC472006
0.9119 High Similarity NPC283041
0.9116 High Similarity NPC67650
0.9116 High Similarity NPC1704
0.9114 High Similarity NPC191930
0.9108 High Similarity NPC215612
0.9108 High Similarity NPC472964
0.9103 High Similarity NPC36217
0.9103 High Similarity NPC472055
0.9103 High Similarity NPC200594
0.9103 High Similarity NPC472902
0.9097 High Similarity NPC241904
0.9097 High Similarity NPC300727
0.9091 High Similarity NPC38898
0.9091 High Similarity NPC16286
0.9091 High Similarity NPC67396
0.9091 High Similarity NPC20541
0.9085 High Similarity NPC475116
0.9079 High Similarity NPC179178
0.9067 High Similarity NPC260946
0.9067 High Similarity NPC107625
0.9067 High Similarity NPC32058
0.9067 High Similarity NPC85734
0.9067 High Similarity NPC138978
0.906 High Similarity NPC27106
0.9057 High Similarity NPC472452
0.9054 High Similarity NPC474385
0.9051 High Similarity NPC7483
0.9051 High Similarity NPC475985
0.9045 High Similarity NPC473106
0.9045 High Similarity NPC103201
0.9045 High Similarity NPC349525
0.9038 High Similarity NPC476242
0.9038 High Similarity NPC238381
0.9038 High Similarity NPC477410
0.9032 High Similarity NPC24640
0.9032 High Similarity NPC274730
0.9032 High Similarity NPC197751
0.9026 High Similarity NPC18727
0.9007 High Similarity NPC476463
0.9007 High Similarity NPC210320
0.9 High Similarity NPC83272
0.9 High Similarity NPC6588
0.9 High Similarity NPC477154
0.9 High Similarity NPC117854
0.8994 High Similarity NPC475888
0.8994 High Similarity NPC326520
0.8994 High Similarity NPC471788
0.8987 High Similarity NPC211107
0.8987 High Similarity NPC201800
0.8987 High Similarity NPC48860
0.8981 High Similarity NPC228785
0.8981 High Similarity NPC14353
0.8981 High Similarity NPC155302
0.8981 High Similarity NPC56085
0.8981 High Similarity NPC321399
0.8981 High Similarity NPC292415
0.8981 High Similarity NPC161947
0.898 High Similarity NPC471819
0.8974 High Similarity NPC475267
0.8974 High Similarity NPC48208
0.8974 High Similarity NPC129684
0.8974 High Similarity NPC474836
0.8974 High Similarity NPC156057
0.8974 High Similarity NPC474208
0.8974 High Similarity NPC108456
0.8974 High Similarity NPC179732
0.8974 High Similarity NPC469584
0.8974 High Similarity NPC474055
0.8974 High Similarity NPC472598
0.8974 High Similarity NPC299520
0.8974 High Similarity NPC162869
0.8968 High Similarity NPC470327
0.8968 High Similarity NPC45849
0.8968 High Similarity NPC200761
0.8968 High Similarity NPC99381
0.8968 High Similarity NPC477503
0.8961 High Similarity NPC199773
0.8961 High Similarity NPC236637
0.8961 High Similarity NPC302950
0.8961 High Similarity NPC219582
0.8961 High Similarity NPC289968
0.8954 High Similarity NPC151473
0.8954 High Similarity NPC338131
0.8951 High Similarity NPC471181
0.8947 High Similarity NPC215711
0.8947 High Similarity NPC73411
0.894 High Similarity NPC268366
0.894 High Similarity NPC473023
0.8938 High Similarity NPC13481
0.8938 High Similarity NPC207575
0.8938 High Similarity NPC477517
0.8938 High Similarity NPC170245
0.8931 High Similarity NPC186686
0.8931 High Similarity NPC474350
0.8931 High Similarity NPC474240
0.8924 High Similarity NPC87431
0.8924 High Similarity NPC61010
0.8924 High Similarity NPC201560
0.8924 High Similarity NPC117985
0.8924 High Similarity NPC40491
0.8924 High Similarity NPC474186
0.8924 High Similarity NPC278052
0.8924 High Similarity NPC112418
0.8924 High Similarity NPC474779
0.8919 High Similarity NPC158472
0.8917 High Similarity NPC87317
0.8917 High Similarity NPC210459
0.8917 High Similarity NPC315157
0.8917 High Similarity NPC100123
0.8917 High Similarity NPC45846
0.8917 High Similarity NPC85121
0.8912 High Similarity NPC472602
0.8912 High Similarity NPC212693
0.8912 High Similarity NPC94248
0.891 High Similarity NPC472050
0.891 High Similarity NPC472626
0.891 High Similarity NPC317383
0.891 High Similarity NPC209614
0.891 High Similarity NPC235165
0.891 High Similarity NPC35038
0.891 High Similarity NPC470328
0.891 High Similarity NPC278778
0.891 High Similarity NPC195796
0.891 High Similarity NPC320825
0.891 High Similarity NPC250922
0.891 High Similarity NPC326037
0.891 High Similarity NPC291878
0.891 High Similarity NPC255106
0.891 High Similarity NPC13858
0.8903 High Similarity NPC25127
0.8903 High Similarity NPC287504
0.8903 High Similarity NPC89474
0.8903 High Similarity NPC192189
0.8896 High Similarity NPC75695
0.8889 High Similarity NPC4423
0.8889 High Similarity NPC77325
0.8882 High Similarity NPC472036
0.8882 High Similarity NPC116745
0.8882 High Similarity NPC474024
0.8882 High Similarity NPC298847
0.8875 High Similarity NPC293319
0.8875 High Similarity NPC8070
0.8875 High Similarity NPC112981
0.8868 High Similarity NPC471745
0.8868 High Similarity NPC474763
0.8867 High Similarity NPC258307
0.8861 High Similarity NPC472630
0.8861 High Similarity NPC155101
0.8861 High Similarity NPC263449
0.8861 High Similarity NPC287328
0.8861 High Similarity NPC282009
0.8861 High Similarity NPC470326
0.8861 High Similarity NPC299436
0.8861 High Similarity NPC475886
0.8861 High Similarity NPC471744
0.8861 High Similarity NPC200746
0.8861 High Similarity NPC470183

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC82592 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8961 High Similarity NPD1934 Approved
0.879 High Similarity NPD4868 Clinical (unspecified phase)
0.8782 High Similarity NPD2393 Clinical (unspecified phase)
0.875 High Similarity NPD6232 Discontinued
0.8725 High Similarity NPD970 Clinical (unspecified phase)
0.8662 High Similarity NPD2801 Approved
0.8642 High Similarity NPD6166 Phase 2
0.8642 High Similarity NPD6168 Clinical (unspecified phase)
0.8642 High Similarity NPD6167 Clinical (unspecified phase)
0.8627 High Similarity NPD2532 Approved
0.8627 High Similarity NPD2534 Approved
0.8627 High Similarity NPD2533 Approved
0.8589 High Similarity NPD7473 Discontinued
0.8553 High Similarity NPD3882 Suspended
0.8545 High Similarity NPD7074 Phase 3
0.8544 High Similarity NPD1465 Phase 2
0.8537 High Similarity NPD3818 Discontinued
0.8503 High Similarity NPD4338 Clinical (unspecified phase)
0.8491 Intermediate Similarity NPD3817 Phase 2
0.8485 Intermediate Similarity NPD7054 Approved
0.8485 Intermediate Similarity NPD5844 Phase 1
0.8446 Intermediate Similarity NPD230 Phase 1
0.8434 Intermediate Similarity NPD7472 Approved
0.8354 Intermediate Similarity NPD4380 Phase 2
0.8323 Intermediate Similarity NPD1511 Approved
0.8313 Intermediate Similarity NPD7819 Suspended
0.8274 Intermediate Similarity NPD6797 Phase 2
0.8274 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8272 Intermediate Similarity NPD7075 Discontinued
0.8225 Intermediate Similarity NPD7251 Discontinued
0.8221 Intermediate Similarity NPD6234 Discontinued
0.8217 Intermediate Similarity NPD1512 Approved
0.8199 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD7808 Phase 3
0.8171 Intermediate Similarity NPD5494 Approved
0.816 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD37 Approved
0.8098 Intermediate Similarity NPD4965 Approved
0.8098 Intermediate Similarity NPD4966 Approved
0.8098 Intermediate Similarity NPD4967 Phase 2
0.8095 Intermediate Similarity NPD7228 Approved
0.8089 Intermediate Similarity NPD6799 Approved
0.8072 Intermediate Similarity NPD5711 Approved
0.8072 Intermediate Similarity NPD5710 Approved
0.8052 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD6801 Discontinued
0.8012 Intermediate Similarity NPD6599 Discontinued
0.8012 Intermediate Similarity NPD6959 Discontinued
0.8 Intermediate Similarity NPD1549 Phase 2
0.7961 Intermediate Similarity NPD447 Suspended
0.7933 Intermediate Similarity NPD3027 Phase 3
0.7927 Intermediate Similarity NPD5402 Approved
0.7925 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD1510 Phase 2
0.7922 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD7199 Phase 2
0.7898 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD4628 Phase 3
0.7895 Intermediate Similarity NPD943 Approved
0.7895 Intermediate Similarity NPD1240 Approved
0.7871 Intermediate Similarity NPD2935 Discontinued
0.7853 Intermediate Similarity NPD7411 Suspended
0.7836 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD3749 Approved
0.7818 Intermediate Similarity NPD5353 Approved
0.7818 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD6559 Discontinued
0.7792 Intermediate Similarity NPD1607 Approved
0.7785 Intermediate Similarity NPD3750 Approved
0.7784 Intermediate Similarity NPD919 Approved
0.7778 Intermediate Similarity NPD1613 Approved
0.7778 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD1653 Approved
0.7756 Intermediate Similarity NPD2796 Approved
0.7736 Intermediate Similarity NPD6190 Approved
0.7727 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2800 Approved
0.7716 Intermediate Similarity NPD5403 Approved
0.7716 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD9269 Phase 2
0.7701 Intermediate Similarity NPD7685 Pre-registration
0.7682 Intermediate Similarity NPD9494 Approved
0.7665 Intermediate Similarity NPD7768 Phase 2
0.7661 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD1551 Phase 2
0.764 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD5242 Approved
0.7602 Intermediate Similarity NPD3926 Phase 2
0.76 Intermediate Similarity NPD7240 Approved
0.7593 Intermediate Similarity NPD5401 Approved
0.7588 Intermediate Similarity NPD1247 Approved
0.7572 Intermediate Similarity NPD3751 Discontinued
0.7566 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD8151 Discontinued
0.7562 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD3787 Discontinued
0.7516 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD3226 Approved
0.7514 Intermediate Similarity NPD8313 Approved
0.7514 Intermediate Similarity NPD8312 Approved
0.75 Intermediate Similarity NPD920 Approved
0.7486 Intermediate Similarity NPD8150 Discontinued
0.7485 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD2346 Discontinued
0.7468 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD3748 Approved
0.7452 Intermediate Similarity NPD6651 Approved
0.7432 Intermediate Similarity NPD9268 Approved
0.7421 Intermediate Similarity NPD6099 Approved
0.7421 Intermediate Similarity NPD6100 Approved
0.7419 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD7435 Discontinued
0.7391 Intermediate Similarity NPD1243 Approved
0.7391 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD1933 Approved
0.7378 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD2799 Discontinued
0.7345 Intermediate Similarity NPD5953 Discontinued
0.733 Intermediate Similarity NPD7286 Phase 2
0.7326 Intermediate Similarity NPD6776 Approved
0.7326 Intermediate Similarity NPD6777 Approved
0.7326 Intermediate Similarity NPD6781 Approved
0.7326 Intermediate Similarity NPD6778 Approved
0.7326 Intermediate Similarity NPD6779 Approved
0.7326 Intermediate Similarity NPD6782 Approved
0.7326 Intermediate Similarity NPD6780 Approved
0.7321 Intermediate Similarity NPD6386 Approved
0.7321 Intermediate Similarity NPD6385 Approved
0.7317 Intermediate Similarity NPD7390 Discontinued
0.7305 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD8434 Phase 2
0.7284 Intermediate Similarity NPD1652 Phase 2
0.7278 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7266 Discontinued
0.7256 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD7033 Discontinued
0.7249 Intermediate Similarity NPD5005 Approved
0.7249 Intermediate Similarity NPD5006 Approved
0.7248 Intermediate Similarity NPD9545 Approved
0.7241 Intermediate Similarity NPD7229 Phase 3
0.7237 Intermediate Similarity NPD9717 Approved
0.7216 Intermediate Similarity NPD7783 Phase 2
0.7216 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4060 Phase 1
0.7208 Intermediate Similarity NPD1203 Approved
0.7197 Intermediate Similarity NPD3764 Approved
0.719 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD8127 Discontinued
0.7179 Intermediate Similarity NPD6832 Phase 2
0.7171 Intermediate Similarity NPD422 Phase 1
0.717 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5124 Phase 1
0.717 Intermediate Similarity NPD6355 Discontinued
0.7165 Intermediate Similarity NPD7874 Approved
0.7165 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2344 Approved
0.7134 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4110 Phase 3
0.7128 Intermediate Similarity NPD4420 Approved
0.7124 Intermediate Similarity NPD1608 Approved
0.712 Intermediate Similarity NPD7697 Approved
0.712 Intermediate Similarity NPD7696 Phase 3
0.712 Intermediate Similarity NPD7680 Approved
0.712 Intermediate Similarity NPD7698 Approved
0.7118 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD9493 Approved
0.7099 Intermediate Similarity NPD5405 Approved
0.7099 Intermediate Similarity NPD5404 Approved
0.7099 Intermediate Similarity NPD5408 Approved
0.7099 Intermediate Similarity NPD5406 Approved
0.7089 Intermediate Similarity NPD411 Approved
0.7089 Intermediate Similarity NPD2313 Discontinued
0.7089 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD6798 Discontinued
0.7083 Intermediate Similarity NPD7871 Phase 2
0.7083 Intermediate Similarity NPD7870 Phase 2
0.7074 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD6674 Discontinued
0.7073 Intermediate Similarity NPD2654 Approved
0.7072 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD4908 Phase 1
0.7068 Intermediate Similarity NPD6823 Phase 2
0.7062 Intermediate Similarity NPD2403 Approved
0.7062 Intermediate Similarity NPD7701 Phase 2
0.7059 Intermediate Similarity NPD3705 Approved
0.7059 Intermediate Similarity NPD6535 Approved
0.7059 Intermediate Similarity NPD6534 Approved
0.7039 Intermediate Similarity NPD4626 Approved
0.7035 Intermediate Similarity NPD8455 Phase 2
0.703 Intermediate Similarity NPD8166 Discontinued
0.7024 Intermediate Similarity NPD6273 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data